KRAS- and BRAF-Mediated Methylation Signatures in Colorectal Cancers and Polyps

肠癌是影响澳大利亚人最常见的癌症之一。我们假设有不同类型的肠癌，这取决于不同的基因可以被异常失活，这些亚组具有不同的临床特征和对治疗的反应。我们的目标是确定这些亚组的主要基因变化，这将在未来允许基因标记的早期检测以及个性化患者治疗的可能性的发展。

Bowel cancer is one of the most common cancers affecting Australians. We hypothesise that there are different types of bowel cancer depending on different genes that can be inactivated abnormally, and these subgroups have different clinical features and responses to therapy. We aim to identify the major gene changes that characterise these subgroups, which will in the future allow the development of gene markers for early detection as well as the possibility of individualised patient therapy.